INFLUENCE OF VITAMIN D ON THE STATE OF CARBOHYDRATE METABOLISM IN COVID-19 RECONVALENTS WITH FIRST DIAGNOSED TYPE 2 DIABETES

  2. 2023
  3. INFLUENCE OF VITAMIN D ON THE STATE OF CARBOHYDRATE METABOLISM IN COVID-19 RECONVALENTS WITH FIRST DIAGNOSED TYPE 2 DIABETES

Romeyko D. Y., Gushcha S. G., Volyanska V. S., Stepanova N. Z., Polskakova T. V. Stepanova V. S.

INFLUENCE OF VITAMIN D ON THE STATE OF CARBOHYDRATE METABOLISM IN COVID-19 RECONVALENTS WITH FIRST DIAGNOSED TYPE 2 DIABETES

Show/Download

About the author:

Romeyko D. Y., Gushcha S. G., Volyanska V. S., Stepanova N. Z., Polskakova T. V. Stepanova V. S.

Heading:

CLINICAL AND EXPERIMENTAL MEDICINE

Type of article:

Scientific article

Annotation:

Vitamin D deficiency was detected in patients after COVID-19 with newly diagnosed type 2 diabetes mellitus (T2DM). Patients were divided into two groups. Group 1 consisted of patients receiving standard oral glucose-lowering therapy. The second group consisted of patients who, in addition to standard therapy, received a drug with a high content of vitamin D. It was found that the use of a drug with vitamin D in the treatment of these patients leads to compensation for carbohydrate metabolism disorders, improves the course of T2DM, restores the level of vitamin D, which helps to reduce the risk of cardiovascular disorders.

Tags:

COVID-19, post-COVID syndrome, type 2 diabetes mellitus, vitamin D

Bibliography:

  1. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022 Apr;22(4):e102-e107. DOI: 10.1016/S1473- 3099(21)00703-9.
  2. Boix V, Merino E. Síndrome post-COVID. El desafío continúa. Med Clin (Barc). 2022;158:178-180. DOI: 10.1016/j.medcle.2021.10.005.
  3. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020.
  4. Proal AD, Van Elzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021 Jun 23;12:698169. DOI: 10.3389/fmicb.2021.698169.
  5. Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its Management. Int J Biol Sci. 2022 Jul 11;18(12):4768-4780. DOI: 10.7150/ ijbs.75056.
  6. Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB, RECOVER Mechanistic Pathway Task Force. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023 Mar 22;12:e86002. DOI: 10.7554/eLife.86002.
  7. Kothandaraman N, Rengaraj A, Xue B, Yew WS, Velan SS, Karnani N, et al. COVID-19 endocrinopathy with hindsight from SARS. Am J Physiol Endocrinol Metab. 2021 Jan 1;320(1):E139-E150. DOI: 10.1152/ajpendo. 00480.2020.
  8. Tang J. COVID-19 Pandemic and Osteoporosis in Elderly Patients. Aging Dis. 2022 Jul 11;13(4):960-969. DOI: 10.14336/AD.2021.1201.
  9. Mankovsky B, Halushko O. COVID-19 in diabetes patients in Ukraine: lessons for doctors and patients. Georgian Med News. 2020 Apr;(301):105-112.
  10. Ilic I, Ilic M. Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review. Life. 2023;13(6):1233. DOI: https://doi.org/ 10.3390/ life13061233.
  11. Li MY, Li L, Zhang Y, Xiao-Sheng W. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(45). DOI: https://doi.org/10.1186/s40249-020-00662-x.
  12. Samavati L, Uhal BD. ACE2, Much More Than Just a Receptor for SARS-COV-2. Front Cell Infect Microbiol. 2020 Jun 5;10:317. DOI: 10.3389/fcimb.2020.00317.
  13. South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1084-H1090. DOI: 10.1152/ajpheart.00217.2020.
  14. Ocaranza MP, Jalil JE. Protective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling. Int J Hypertens. 2012;2012:594361. DOI: 10.1155/2012/594361.
  15. Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020 Jun;76:14-20. DOI: 10.1016/j.ejim.2020.04.037.
  16. Unnikrishnan R, Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes. 2021 Jun 23;11(1):21. DOI: 10.1038/s41387- 021-00163-2.
  17. Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. Pathogens. 2020;9(3):231. DOI: https://doi.org/10.3390/pathogens9030231.
  18. Suwanwongse K, Shabarek N. Newly diagnosed diabetes mellitus, DKA, and COVID-19: Causality or coincidence? A report of three cases. J Med Virol. 2021 Feb;93(2):1150-1153. DOI: 10.1002/jmv.26339.
  19. Berridge MJ. Vitamin D deficiency and diabetes. Biochem J. 2017 Mar 24;474(8):1321-1332. DOI: 10.1042/BCJ20170042.
  20. Gröber U, Holick MF. Diabetes Prevention: Vitamin D Supplementation May Not Provide Any Protection If There Is No Evidence of Deficiency! Nutrients. 2019;11(11):2651. DOI: https://doi.org/10.3390/nu11112651.
  21. Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger М, Berisha АТ, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74:1498-1513. DOI: https://doi.org/10.1038/s41430-020-0558-y.
  22. Grygorieva N, Tronko M, Kovalenko V, Komisarenko S, Tatarchuk T, Dedukh N, et al. Diagnosis, prevention and treatment of vitamin D deficiency in adults: Ukrainian experts consensus statement. Pain, Joints, Spine. 2023;13(2):60-76. DOI: https://doi.org/10.22141/ pjs.13.2.2023.368.
  23. Haimi M, Kremer R. Vitamin D deficiency/insufficiency from childhood to adulthood: Insights from a sunny country. World J Clin Pediatr. 2017 Feb 8;6(1):1-9. DOI: 10.5409/wjcp.v6.i1.1.
  24. Álvarez-Mercado AI, Mesa MD, Gil Á. Vitamin D: Role in chronic and acute diseases. Encyclopedia of Human Nutrition. 2023:535-544. DOI: 10.1016/B978-0-12-821848-8.00101-3.
  25. Bilezikian JP, Formenti AM, Adler RA, Binkley N, Bouillon R, Lazaretti-Castro M, et al. Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all? Rev Endocr Metab Disord. 2021 Dec;22(4):1201-1218. DOI: 10.1007/s11154-021-09693-7.
  26. Ministerstvo okhorony zdorovia Ukrainy. Derzhavnyi ekspertnyi tsentr Ministerstvo okhorony zdorovia Derzhavna naukova ustanova «Naukovo-praktychnyi tsentr profilaktychnoi i klinichnoi medytsyny» Derzhavnoho upravlinnia spravamy». Klinichne vedennia patsiientiv z COVID-19 «ZhYVA» Klinichna nastanova. Kyyiv: MOZ Ukrainy; 2021. 143 s. DOI: https://doi.org/10.31612/COVID. [in Ukrainian].
  27. COVID-19 rapid guideline: vitamin D. NICE guideline [NG187]; 2020 [updated 2022 July 14]. Available from: https://www.nice.org.uk/ guidance/ ng187/resources/covid19-rapid-guideline-vitamin-d-pdf-66142026720709.
  28. Ramos-Hernández WM, Soto LF, Del Rosario-Trinidad M, Farfan-Morales CN, De Jesús-González LA, Martínez-Mier G, et al. Leukocyte glucose index as a novel biomarker for COVID-19 severity. Sci Rep. 2022;12:14956. DOI: https://doi.org/10.1038/s41598-022-18786-5.
  29. Rafiq S, Jeppesen PB. Is Hypovitaminosis D Related to Incidence of Type 2 Diabetes and High Fasting Glucose Level in Healthy Subjects: A Systematic Review and Meta-Analysis of Observational Studies. Nutrients. 2018 Jan 10;10(1):59. DOI: 10.3390/nu10010059.
  30. Aludwan M, Kobylіak N, Komisarenko Y. Metabolic predictors and vitamin D deficiency in patients with type 2 diabetes mellitus. International Journal of Endocrinology (Ukraine). 2019;15(6):459-468. DOI: https://doi.org/10. 22141/2224-0721.15.6.2019.185408. [in Ukrainian].
  31. Ramasamy I. Vitamin D Metabolism and Guidelines for Vitamin D Supplementation. Clin Biochem Rev. 2020 Dec;41(3):103-126. DOI: 10.33176/AACB-20-00006.
  32. Huang J, Zhu L, Bai X, Jia X, Lu Y, Deng A, et al. Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes. Infect Dis Ther. 2020 Dec;9(4):981-1002. DOI: 10.1007/s40121-020-00359-6.
  33. Qi LY, Liu HX, Cheng LC, Luo Y, Yang SQ, Chen X, et al. Prognostic Value of the Leuko-Glycemic Index in Acute Myocardial Infarction Patients with or without Diabetes. Diabetes Metab Syndr Obes. 2022 Jun 9;15:1725-1736. DOI: 10.2147/DMSO.S356461.
  34. Demir М. The leuko-glycemic index can predict multivessel disease in the elderly acute myocardial infarction population? a retrospective cohort study. J Health Sci Med. 2023;6(5):1119-1124. DOI: 10.32322/jhsm.1349575/.
  35. Ghelani D, Alesi S, Mousa A. Vitamin D and COVID-19: An Overview of Recent Evidence. Int J Mol Sci. 2021 Sep 29;22(19):10559. DOI: 10.3390/ijms221910559.
  36. Al Ghadeer HA, Al Ramadan MS, Al Amer MM, Alshawaf MJ, Alali FJ, Bubshait AA, et al. Vitamin D Serum Levels in Type 2 Diabetic Patients: A Cross-Sectional Study. Cureus. 2022 Feb 24;14(2):e22558. DOI: 10.7759/cureus.22558.
  37. Seshadri KG , Tamilselvan В, Rajendran А. Role of Vitamin D in Diabetes. Journal of Endocrinology and Metabolism. 2011;1(2):47-56. Available from: https://www.jofem.org/index.php/jofem/article/view/23/32.
  38. Leung PS. The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. Nutrients. 2016;8(3):147. DOI: https://doi.org/10.3390/nu8030147.
  39. Huang HY, Lin TW, Hong ZX, Lim LM. Vitamin D and Diabetic Kidney Disease. Int J Mol Sci. 2023 Feb 13;24(4):3751. DOI: 10.3390/ijms 24043751.
  40. Martens PJ, Gysemans C, Verstuyf A, Mathieu AC. Vitamin D’s Effect on Immune Function. Nutrients. 2020 Apr 28;12(5):1248. DOI: 10.3390/nu12051248.
  41. Singh SK, Jain R, Singh S. Vitamin D deficiency in patients with diabetes and COVID- 19 infection. Diabetes Metab Syndr. 2020 SepOct;14(5):1033-1035. DOI: 10.1016/j.dsx.2020.06.071.
  42. Decyk A, Kobylińska M, Antosik K, Kurowska K. Vitamin D in SARS-CoV-2 infection. Rocz Panstw Zakl Hig. 2022;73(1):5-12. DOI: 10.32394/rpzh.2022.0191.
  43. Ręka G, Korzeniowska A, Machowiec P, Maksymowicz M, Piecewicz-Szczęsna H. Impact of level of vitamin D in the body on the severity of COVID-19 – review of the literature. Przegl Epidemiol. 2020;74(4):583-595. DOI: 10.32394/pe.74.50.

Publication of the article:

«Bulletin of problems biology and medicine», 2023 Issue 4, 171, 236-245 pages, index UDC 616.98:578.834]-06:616.379-008.64-085: [615,356:577.161.2-085

DOI:

10.29254/2077-4214-2023-4-171-236-245

2023 Issue 4, 171
COVID-19 post-COVID syndrome type 2 diabetes mellitus vitamin D
22.12.2023
Was this article helpful?
1
2

Leave a Reply

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.